HCW Biologics Inc.

NASDAQ: HCWB · Real-Time Price · USD
3.28
-0.12 (-3.53%)
At close: Aug 21, 2025, 3:49 PM
3.36
2.44%
Pre-market: Aug 22, 2025, 08:42 AM EDT

HCW Biologics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-11.4M -24.75M -30.02M -37.33M -38.37M -27.39M -24.99M -19.73M -18.71M -17.91M -14.9M -12.66M -12.84M -12.08M -12.86M -7.63M -6.24M -6.27M
Depreciation & Amortization
1.52M 1.36M 1.18M 776.43K 925.44K 1.08M 1.14M 1.12M 1.01M 873.92K 717.85K 552.28K 510.4K 515.7K 531.72K 599.82K 603.58K 606.81K
Stock-Based Compensation
1.08M 1.04M 1.01M 978.21K 965.63K 989.23K 1M 1.03M 1.11M 1.12M 1.12M 834K 533.34K 272.23K 11.88K 11.88K 10.22K n/a
Other Working Capital
132.97K 271.09K 775.08K 1.37M 963.24K -5M -5.14M -5.15M -4.92M 1.09M 2.35M 1.15M -422.76K -1.28M -2.8M -4.32M -2.9M -2.46M
Other Non-Cash Items
-1.73M 150K -418 5.25M 5.21M 5.1M 4.98M -331.67K -245.57K -109.16K 188.46K 710.08K 665.24K 640.39K -112.25K -545.44K -545.44K -545.44K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-2.03M 8.07M 13.6M 15.04M 13.32M -2.25M -4.64M -4.5M -2.3M 3.6M 2.49M 585.67K -1.65M -430.72K 1.46M -3.57M -2.59M -3.73M
Operating Cash Flow
-12.56M -14.14M -14.23M -15.29M -17.95M -22.48M -22.51M -22.41M -19.13M -12.43M -10.39M -9.97M -12.78M -11.08M -10.98M -11.14M -8.77M -9.94M
Capital Expenditures
-150.47K -131.91K -261.62K -3.86M -4.46M -6.03M -6.2M -2.56M -12.1M -10.55M -10.28M -10.23M -60.45K -47.54K -47.26K -63.8K -164.88K -164.88K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -4.05K -4.05K -4.05K -4.05K n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a 10M 10M 10M 10M 16.98M 16.98M 24.98M 24.98M 8M 8M n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -34.97M -34.97M -34.97M -34.97M n/a n/a
Investing Cash Flow
-150.47K -131.91K -261.62K -3.86M 5.54M 3.97M 3.8M 7.44M 4.89M 6.43M 14.71M 14.75M -27.03M -27.02M -35.02M -35.03M -164.88K -109.1K
Debt Repayment
3.23M 5.03M 6.79M 6.41M 3.6M 1.68M -38.27K -8.98K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
6.14M 2.3M 2.32M n/a n/a n/a n/a -45.68K 6.26M 6.26M 6.26M 6.3M -5.84M -6.66M -6.76M -6.2M 5.81M 6.63M
Financial Cash Flow
13.99M 11.29M 15.57M 8.93M 6.12M 4.21M -14.53K -39.13K 6.27M 6.27M 6.27M 6.32M 50.18M 49.36M 49.27M 54.81M 10.81M 11.63M
Net Cash Flow
1.28M -2.98M 1.08M -10.22M -6.29M -14.31M -18.73M -15M -7.97M 272.58K 10.6M 11.1M 10.37M 11.26M 3.27M 8.64M 1.88M 1.58M
Free Cash Flow
-12.71M -14.27M -14.49M -19.15M -22.41M -28.51M -28.72M -24.96M -31.23M -22.98M -20.66M -20.2M -12.84M -11.13M -11.02M -11.2M -8.93M -10.05M